Roche, mirroring Novartis, guilty of most serious marketing breach for Polivy website

For the second time this month, the U.K.'s drug marketing body, the PMCPA, has found a Switzerland-based Big Pharma to be in significant violation of its rules. The breach in question falls under Clause 2, which pertains to "bringing discredit upon, and reducing confidence in, the pharmaceutical industry."